文献速递瓣膜病与结构性心脏病

二尖瓣环钙化相关瓣膜功能障碍中跨二尖瓣压差的预后价值

Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction.
PubMed 文献 · Eur Heart J · 2020-01-01

该研究基于2001至2019年机构超声心动图数据库,纳入5754例二尖瓣环钙化(MAC)且平均跨二尖瓣压差(MG)≥3 mmHg的患者,按MG分为低(3-5 mmHg)、中(5-10 mmHg)、高(≥10 mmHg)三组。结果显示MG与全因死亡独立相关(每升高1 mmHg,校正HR 1.064,95%CI 1.049-1.080),合并二尖瓣反流仅在低压差组与死亡相关。

要点

  • MAC相关瓣膜功能障碍患者中,平均跨二尖瓣压差升高与全因死亡风险独立相关。
  • 合并二尖瓣反流仅在低压差(3-5 mmHg)组与死亡相关,在更高压差组预后价值逐渐减弱。
  • 高圧差组1年、5年、10年生存率分别为67%、25%、11%,低于低圧差组。

核心结论

  • 在MAC相关二尖瓣功能障碍中,平均跨二尖瓣压差经年龄、性别及MAC相关危险因素校正后仍与死亡率升高相关。
  • 合并二尖瓣反流在低圧差范围(3-5 mmHg)与超额死亡相关,但在更高压差时预后重要性逐渐丧失。

研究设计与样本

  • 回顾性机构超声心动图数据库研究,纳入2001至2019年MAC且MG≥3 mmHg的患者共5754例。
  • 按MG分层:低圧差组(3-5 mmHg,n=3927)、中圧差组(5-10 mmHg,n=1476)、高圧差组(≥10 mmHg,n=351)。
  • 平均年龄78±11岁,女性占67%。
  • 主要结局为全因死亡,模型校正年龄、性别及MAC相关危险因素(高血压、糖尿病、冠心病、慢性肾脏病)。

主要发现

  • 低圧差组1年、5年、10年生存率分别为77%、42%、18%;中圧差组分别为73%、38%、17%;高圧差组分别为67%、25%、11%(组间log-rank P < 0.001)。
  • MG与死亡率独立相关(每升高1 mmHg,校正HR 1.064,95%CI 1.049-1.080)。
  • 二尖瓣反流严重程度在低圧差组与死亡率相关(P < 0.001),在中圧差组(P = 0.166)和高圧差组(P = 0.372)不相关。

关键数值与推荐

  • MG分层界值:低3-5 mmHg、中5-10 mmHg、高≥10 mmHg。
  • 二尖瓣反流分布:无/微量32%、轻度42%、中度23%、重度3%。

临床怎么用

  • 对MAC相关二尖瓣功能障碍患者,应测量并报告平均跨二尖瓣压差以辅助风险分层。
  • 低圧差(3-5 mmHg)合并二尖瓣反流者死亡风险增高,需重点关注。
  • 高圧差(≥10 mmHg)患者预后较差,无论二尖瓣反流严重程度如何。

局限性

  • 为单中心回顾性超声数据库研究,可能存在选择偏倚。
  • 仅纳入MG≥3 mmHg的MAC患者,未涵盖更低压差人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to define the natural history of patients with mitral annular calcification (MAC)-related mitral valve dysfunction and to assess the prognostic importance of mean transmitral pressure gradient (MG) and impact of concomitant mitral regurgitation (MR). METHODS AND RESULTS: The institutional echocardiography database was examined from 2001 to 2019 for all patients with MAC and MG ≥3 mmHg. A total of 5754 patients were stratified by MG in low (3-5 mmHg, n = 3927), mid (5-10 mmHg, n = 1476), and high (≥10 mmHg, n = 351) gradient. The mean age was 78 ± 11 years, and 67% were female. MR was none/trace in 32%, mild in 42%, moderate in 23%, and severe in 3%. Primary outcome was all-cause mortality, and outcome models were adjusted for age, sex, and MAC-related risk factors (hypertension, diabetes, coronary artery disease, chronic kidney disease). Survival at 1, 5, and 10 years was 77%, 42%, and 18% in the low-gradient group; 73%, 38%, and 17% in the mid-gradient group; and 67%, 25%, and 11% in the high-gradient group, respectively (log-rank P < 0.001 between groups). MG was independently associated with mortality (adjusted HR 1.064 per 1 mmHg increase, 95% CI 1.049-1.080). MR severity was associated with mortality at low gradients (P < 0.001) but not at higher gradients (P = 0.166 and 0.372 in the mid- and high-gradient groups, respectively). CONCLUSION: In MAC-related mitral valve dysfunction, mean transmitral gradient is associated with increased mortality after adjustment for age, sex, and MAC-related risk factors. Concomitant MR is associated with excess mortality in low-gradient ranges (3-5 mmHg) but gradually loses prognostic importance at higher gradients, indicating prognostic utility of transmitral gradient in MAC regardless of MR severity.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Bertrand PB, Churchill TW, Yucel E, et al. Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction. Eur Heart J. 2020. PMID: 33221855. doi:10.1093/eurheartj/ehaa819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。